Portfolio holdings of Richard Pzena - Hancock Classic Value. Richard Pzena - Hancock Classic Value stock picks:. Stock Holdings page.
Richard Pzena - Hancock Classic Value
i
Goal and Strategy
The Fund seeks long-term growth of capital by normally investing at least 80% of its net assets in domestic equity securities. In managing the portfolio, the subadviser seeks to identify companies that it believes are currently undervalued relative to the market, based on estimated future earnings and cash flow. In choosing individual securities, the subadviser screens a dynamic universe of the 500 largest publicly traded U.S. companies.
The Fund seeks long-term growth of capital by normally investing at least 80% of its net assets in domestic equity securities. In managing the portfolio, the subadviser seeks to identify companies that it believes are currently undervalued relative to the market, based on estimated future earnings and cash flow. In choosing individual securities, the subadviser screens a dynamic universe of the 500 largest publicly traded U.S. companies.
Period: Q4 2024
Portfolio date: 31 Dec 2024
No. of stocks: 33
Portfolio value: $749,265,000
History | Stock | % of Portfolio |
RecentActivity | Shares | ReportedPrice* | Value | Current Price |
+/-Reported Price |
52Week Low |
52Week High |
|
≡ | CVS - CVS Health Corp. | 5.22 | Add 15.47% | 870,779 | $44.89 | $39,089,000 | $67.14 | 49.57% | $43.01 | $76.49 | |
≡ | HUM - Humana Inc. | 5.04 | Add 31.47% | 148,948 | $253.71 | $37,790,000 | $264.58 | 4.28% | $211.87 | $402.60 | |
≡ | BAX - Baxter International Inc. | 5.00 | Add 2.44% | 1,284,838 | $29.16 | $37,466,000 | $33.75 | 15.74% | $28.20 | $42.85 | |
≡ | C - Citigroup Inc. | 4.54 | Reduce 46.23% | 483,009 | $70.39 | $33,999,000 | $70.33 | -0.09% | $52.67 | $84.74 | |
≡ | DOW - Dow Inc. | 4.07 | Reduce 30.07% | 759,193 | $40.13 | $30,466,000 | $34.36 | -14.38% | $34.13 | $57.18 | |
≡ | WFC - Wells Fargo | 4.04 | Reduce 48.51% | 431,080 | $70.24 | $30,279,000 | $70.69 | 0.64% | $49.24 | $81.30 | |
≡ | COF - Capital One Financial | 3.98 | Reduce 42.72% | 167,368 | $178.32 | $29,845,000 | $173.53 | -2.69% | $126.86 | $210.67 | |
≡ | GPN - Global Payments Inc. | 3.54 | Reduce 36.85% | 236,829 | $112.06 | $26,539,000 | $97.52 | -12.98% | $90.74 | $132.32 | |
≡ | DG - Dollar General | 3.51 | Add 20.01% | 347,276 | $75.82 | $26,330,000 | $86.10 | 13.56% | $66.43 | $160.38 | |
≡ | FMS - Fresenius Medical Care AG & Co KCaG | 3.51 | Reduce 46.68% | 1,163,170 | $22.64 | $26,334,000 | $24.78 | 9.45% | $17.80 | $25.25 | |
≡ | MGA - Magna International Inc. | 3.51 | Reduce 31.13% | 628,420 | $41.79 | $26,262,000 | $34.00 | -18.64% | $33.30 | $51.94 | |
≡ | MET - MetLife Inc. | 3.05 | Reduce 43.64% | 279,519 | $81.88 | $22,887,000 | $79.23 | -3.24% | $65.87 | $88.48 | |
≡ | LEA - Lear Corp. | 3.03 | Reduce 27.90% | 239,941 | $94.70 | $22,722,000 | $87.96 | -7.12% | $85.57 | $141.23 | |
≡ | SSNC - SS&C Technologies Holdings Inc. | 3.03 | Reduce 47.73% | 299,942 | $75.78 | $22,730,000 | $81.98 | 8.18% | $58.84 | $89.73 | |
≡ | BAC - Bank of America Corp. | 3.02 | Reduce 38.96% | 514,866 | $43.95 | $22,628,000 | $41.25 | -6.14% | $33.33 | $47.68 | |
≡ | EQH - Equitable Holdings Inc. | 3.00 | Reduce 43.75% | 476,398 | $47.17 | $22,472,000 | $51.66 | 9.52% | $34.72 | $55.74 | |
≡ | CHTR - Charter Communications | 2.96 | Reduce 41.39% | 64,699 | $342.77 | $22,177,000 | $369.02 | 7.66% | $236.08 | $415.27 | |
≡ | CTSH - Cognizant Technology Solutions | 2.95 | Reduce 45.15% | 287,033 | $76.90 | $22,073,000 | $75.90 | -1.30% | $63.07 | $90.51 | |
≡ | SHEL - Shell plc | 2.61 | Reduce 28.63% | 312,522 | $62.65 | $19,580,000 | $72.73 | 16.09% | $59.51 | $74.18 | |
≡ | PFE - Pfizer Inc. | 2.55 | Reduce 32.08% | 718,944 | $26.53 | $19,074,000 | $25.21 | -4.98% | $23.71 | $30.55 | |
≡ | SWKS - Skyworks Solutions Inc. | 2.53 | Reduce 33.75% | 213,536 | $88.68 | $18,936,000 | $64.12 | -27.70% | $61.36 | $117.89 | |
≡ | DAL - Delta Air Lines Inc. | 2.51 | Reduce 49.35% | 311,035 | $60.50 | $18,818,000 | $43.84 | -27.54% | $37.09 | $69.81 | |
≡ | BMY - Bristol-Myers Squibb | 2.50 | Reduce 46.07% | 330,566 | $56.56 | $18,697,000 | $60.02 | 6.12% | $38.18 | $63.33 | |
≡ | TSN - Tyson Foods | 2.50 | Reduce 38.04% | 326,635 | $57.44 | $18,762,000 | $62.37 | 8.58% | $52.36 | $65.82 | |
≡ | MDT - Medtronic plc | 2.49 | Reduce 33.39% | 233,881 | $79.88 | $18,682,000 | $87.63 | 9.70% | $74.13 | $95.49 | |
≡ | DOX - Amdocs Ltd. | 2.47 | Reduce 38.73% | 217,807 | $85.14 | $18,544,000 | $90.95 | 6.82% | $73.14 | $92.82 | |
≡ | NWL - Newell Brands Inc. | 2.11 | Reduce 41.53% | 1,588,737 | $9.96 | $15,824,000 | $6.39 | -35.84% | $5.24 | $11.65 | |
≡ | NOV - Nov Inc. | 2.10 | Reduce 18.42% | 1,077,547 | $14.60 | $15,732,000 | $14.99 | 2.67% | $13.70 | $20.89 | |
≡ | VOYA - Voya Financial Inc. | 2.07 | Reduce 29.87% | 225,578 | $68.83 | $15,527,000 | $67.27 | -2.27% | $62.94 | $83.31 | |
≡ | TEL - TE Connectivity plc | 2.01 | Reduce 33.57% | 105,527 | $142.97 | $15,087,000 | $142.13 | -0.59% | $137.67 | $156.33 | |
≡ | PVH - PVH Corp. | 1.99 | Reduce 34.83% | 141,099 | $105.75 | $14,921,000 | $64.69 | -38.83% | $62.94 | $140.93 | |
≡ | UBS - UBS AG | 1.51 | Reduce 37.77% | 374,180 | $30.32 | $11,345,000 | $31.56 | 4.09% | $26.01 | $35.84 | |
≡ | JPM - JPMorgan Chase & Co. | 1.02 | Reduce 63.59% | 31,905 | $239.71 | $7,648,000 | $242.85 | 1.31% | $176.22 | $280.25 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
Sector % analysis
Financials | 26.23 | |
Health Care | 21.09 | |
Consumer Discretionary | 10.64 | |
Information Technology | 9.02 | |
Consumer Staples | 7.72 | |
Technology | 7.51 | |
Materials | 6.68 | |
Services | 5.47 | |
Consumer Goods | 3.51 | |
Energy | 2.10 |
Articles & Commentaries
06 Dec 2024 Pzena investment Management Podcast: Exploring the Impact of AI on Global Equity Markets
08 Aug 2024 Pzena investment Management Podcast: The Power of Patience - Unlocking Value Investing’s Long-Term Rewards
07 Jun 2024 Interview with Caroline Cai of Pzena Investment Management: The science of finding under-valued global gems
24 Jan 2024 Pzena Investment Management Q4 2023 Commentary
26 Oct 2023 Pzena Investment Management Q3 2023 Commentary
26 Sep 2023 In Conversation with Rakesh Bordia, Portfolio Manager of the Pzena Emerging Markets Value Fund
15 Sep 2023 Pzena Investment Management: Energy Transition
26 Apr 2023 Pzena Investment Management Q1 2023 Commentary: The Current Opportunity In Small Caps Globally